Zhitong Financial APP News, Special Pharmaceutical (002728.SZ) issued an announcement that the company recently obtained the "Notice of Approval of Drug Supplement Application" of "Compound Sulfamethoxazole Tablets" approved by the State Drug Administration, and after review, the above drugs passed the consistency evaluation of the quality and efficacy of generic drugs.
It is reported that the compound sulfamethoxazole tablets are sulfonamide antibacterial drugs, which are a compound preparation of sulfamethoxazole (SMZ) and trimethoprim (TMP), which is mainly used to prevent or treat infections caused by sensitive strains.